About iosBio: Revolutionising Global Vaccination
Our mission is to develop and deliver innovative oral, thermostable vaccines for major infectious diseases using our proprietary technology platforms.
We combine cutting-edge science in virology, immunology, and formulation with advanced technologies like Enhanced Surface Display (ESD™) and AI-driven antigen design to create vaccines that offer significant advantages over traditional methods.
Our Experienced Leadership Team
iosBio is led by a dedicated team with extensive experience in biotechnology, vaccine development, clinical trials, business development, and finance.
Wayne Channon
(Exec Chairman)
Wayne is a successful entrepreneur with experience of managing high growth companies from start-up to exit and IPO…
Dr Elliot Bland
(COO)
Elliot is a fellow of Queen Mary University of London, where he held responsibility for commercialisation of life-science projects, non-clinical regulatory packages…
Dr Craig Laferrière
(CDO)
Craig joined iosBio from CANVAX, Novateur Ventures Inc., an international vaccine consulting business…
Ben Warriner
(Financial Advisor)
Ben is a highly experienced finance professional with more than a decade of international leadership experience working within the healthcare sector…
Peter Cozens PhD
Non-Executive Director
Peter has worked for more than 30 years in the pharmaceutical industry, with broad international experience in both the biotechnology and conventional pharmaceutical sectors of the industry…
James Hudleston
Non-Executive Director
James is an entrepreneur, corporate financier and highly successful investor in technology, biotechnology and the resource sector…
Myra Waiman
Non-Executive Director
Myra is a biochemist and worked in hospitals for a number of years before establishing Romney Consultants as a strategy and business consultancy…